Quest Diagnostics, Inc. Live Stock Price Today, Share Analysis and Chart

Name: Quest Diagnostics, Inc.: Is Infosys Ltd. worth buying?
Item: Quest Diagnostics, Inc.
Rating: 2.424541625
Author: Trendlyne DVM scores

Mid-range Performer

about

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing ...

181.79 1.65 (0.92%)

Near 52W High of $185.62

113.4K

XNYS Volume

XNYS 11 Sep, 2025 12:03 PM (EDT)

Dividend

Quest Diagnostics, Inc. has an upcoming dividend of $0.80 per share due on 03 Oct 2025 See details

Medium Financial Strength

50.0 / 100

Mid Valuation

35.8 / 100

Technically Neutral

58.1 / 100

Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM

188

1Yr Price target upside is 4%

16 analysts

Quest Diagnostics Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Quest Diagnostics, Inc. Live Stock Price Today, Share Analysis and Chart

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing ...

Near 52W High of $185.62

SWOT Analysis

Quest Diagnostics Live Price Chart